EvlaBio (Seed)
Funding Details
Awarder
Inbox
Date Award
July 13, 2025
Vertical
biotech
Funding URL
View Funding Page
Funding Amount
$21,000,000
Company Info
Founders
Wenzel von der Heydte, Thomas Kirmeier
Market
cardiovascular and cardiorenal diseases
Location
Switzerland
Coinvestors
Kurma Partners, AdBio Partners, Boehringer Ingelheim Venture Fund, NRW.Venture, HTGF
Company Description

EvlaBio is a Swiss German biotech company focused on developing first-in-class therapeutics for cardiovascular and cardiorenal diseases, specifically targeting Chronic Kidney Disease (CKD) with a novel monoclonal antibody designed to inhibit the pathological FGF23/FGFR4 cardiac signaling axis.

Links
Website
Back to HomeBack to biotech DealsView Funding Announcement